420 related articles for article (PubMed ID: 8413204)
1. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity.
Cafferkey R; Young PR; McLaughlin MM; Bergsma DJ; Koltin Y; Sathe GM; Faucette L; Eng WK; Johnson RK; Livi GP
Mol Cell Biol; 1993 Oct; 13(10):6012-23. PubMed ID: 8413204
[TBL] [Abstract][Full Text] [Related]
2. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.
Lorenz MC; Heitman J
J Biol Chem; 1995 Nov; 270(46):27531-7. PubMed ID: 7499212
[TBL] [Abstract][Full Text] [Related]
3. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
Brown EJ; Albers MW; Shin TB; Ichikawa K; Keith CT; Lane WS; Schreiber SL
Nature; 1994 Jun; 369(6483):756-8. PubMed ID: 8008069
[TBL] [Abstract][Full Text] [Related]
4. Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs.
Cafferkey R; McLaughlin MM; Young PR; Johnson RK; Livi GP
Gene; 1994 Apr; 141(1):133-6. PubMed ID: 8163165
[TBL] [Abstract][Full Text] [Related]
5. Missense mutations at the FKBP12-rapamycin-binding site of TOR1.
Freeman K; Livi GP
Gene; 1996 Jun; 172(1):143-7. PubMed ID: 8654975
[TBL] [Abstract][Full Text] [Related]
6. The tyrosine89 residue of yeast FKBP12 is required for rapamycin binding.
Koser PL; Eng WK; Bossard MJ; McLaughlin MM; Cafferkey R; Sathe GM; Faucette L; Levy MA; Johnson RK; Bergsma DJ; Livi GP
Gene; 1993 Jul; 129(2):159-65. PubMed ID: 8325502
[TBL] [Abstract][Full Text] [Related]
7. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.
Zheng XF; Florentino D; Chen J; Crabtree GR; Schreiber SL
Cell; 1995 Jul; 82(1):121-30. PubMed ID: 7606777
[TBL] [Abstract][Full Text] [Related]
8. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.
Sabatini DM; Erdjument-Bromage H; Lui M; Tempst P; Snyder SH
Cell; 1994 Jul; 78(1):35-43. PubMed ID: 7518356
[TBL] [Abstract][Full Text] [Related]
9. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.
Stan R; McLaughlin MM; Cafferkey R; Johnson RK; Rosenberg M; Livi GP
J Biol Chem; 1994 Dec; 269(51):32027-30. PubMed ID: 7528205
[TBL] [Abstract][Full Text] [Related]
10. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.
Sabers CJ; Martin MM; Brunn GJ; Williams JM; Dumont FJ; Wiederrecht G; Abraham RT
J Biol Chem; 1995 Jan; 270(2):815-22. PubMed ID: 7822316
[TBL] [Abstract][Full Text] [Related]
11. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.
Kunz J; Henriquez R; Schneider U; Deuter-Reinhard M; Movva NR; Hall MN
Cell; 1993 May; 73(3):585-96. PubMed ID: 8387896
[TBL] [Abstract][Full Text] [Related]
12. Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.
Alarcon CM; Cardenas ME; Heitman J
Genes Dev; 1996 Feb; 10(3):279-88. PubMed ID: 8595879
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein.
Koltin Y; Faucette L; Bergsma DJ; Levy MA; Cafferkey R; Koser PL; Johnson RK; Livi GP
Mol Cell Biol; 1991 Mar; 11(3):1718-23. PubMed ID: 1996117
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity sequencing of large proteins: partial structure of the rapamycin-FKBP12 target.
Erdjument-Bromage H; Lui M; Sabatini DM; Snyder SH; Tempst P
Protein Sci; 1994 Dec; 3(12):2435-46. PubMed ID: 7756997
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
Alarcon CM; Heitman J; Cardenas ME
Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010
[TBL] [Abstract][Full Text] [Related]
16. The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity.
Sabatini DM; Pierchala BA; Barrow RK; Schell MJ; Snyder SH
J Biol Chem; 1995 Sep; 270(36):20875-8. PubMed ID: 7673106
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR.
Cruz MC; Goldstein AL; Blankenship J; Del Poeta M; Perfect JR; McCusker JH; Bennani YL; Cardenas ME; Heitman J
Antimicrob Agents Chemother; 2001 Nov; 45(11):3162-70. PubMed ID: 11600372
[TBL] [Abstract][Full Text] [Related]
18. A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus.
Benton BM; Zang JH; Thorner J
J Cell Biol; 1994 Nov; 127(3):623-39. PubMed ID: 7525596
[TBL] [Abstract][Full Text] [Related]
19. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast.
Helliwell SB; Wagner P; Kunz J; Deuter-Reinhard M; Henriquez R; Hall MN
Mol Biol Cell; 1994 Jan; 5(1):105-18. PubMed ID: 8186460
[TBL] [Abstract][Full Text] [Related]
20. FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity.
Cardenas ME; Heitman J
EMBO J; 1995 Dec; 14(23):5892-907. PubMed ID: 8846782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
